AbbVie: What It Is and How It Connects to Manufacturing in India

When you think of AbbVie, a multinational biopharmaceutical company known for drugs like Humira and Skyrizi. It's not just a brand name—it's a major player in how modern medicines are designed, produced, and delivered. AbbVie doesn’t just sell pills. It runs massive, precision-driven manufacturing systems that rely on polymers, packaging materials, and controlled-release technologies. These aren’t just random plastics—they’re engineered materials that keep drugs stable, safe, and effective from factory to patient.

Behind every tablet, injection, or patch AbbVie makes is a chain of manufacturing processes that intersect with industries you might not expect. For example, the capsules holding liquid medicine? Often made from pharmaceutical-grade polymers, specialized plastic compounds designed to resist degradation and control drug release. The blister packs? Made from layered films that require exact polymer blends. Even the tubing in sterile filling lines uses high-purity polymers to avoid contamination. These aren’t generic materials—they’re custom-formulated, regulated, and tested to the highest standards. And guess what? India is becoming one of the top places in the world to make these very materials. Companies like Tirupati Polymers Manufacturing supply the base polymers that go into packaging, delivery systems, and even medical devices used by global pharma giants like AbbVie.

AbbVie’s supply chain doesn’t stop at its own factories. It depends on a network of suppliers—many based in India—for everything from active ingredients to packaging components. Gujarat’s chemical hubs, like Jamnagar and Dahej, produce the raw materials that eventually become the polymers used in drug packaging. The same state that leads India’s chemical output also feeds the global pharma industry. And as AbbVie pushes for more sustainable packaging and single-use systems, demand for high-quality, compliant polymers is only rising. This isn’t theory. It’s happening right now, in factories across India, quietly supporting the medicines millions rely on.

So when you hear "AbbVie," don’t just think of a drug label. Think of the invisible infrastructure behind it—the polymers, the manufacturing precision, the supply chains stretching from Gujarat to Chicago. The posts below dive into exactly that: how polymer production, chemical manufacturing, and government schemes like PLI are reshaping the real-world foundation of global pharma. You’ll see who’s making the materials, where they’re made, and why India is becoming harder to ignore in the drug manufacturing game.

AbbVie and Abbott: Exploring Their Relationship in the Indian Pharma Sector
AbbVie and Abbott: Exploring Their Relationship in the Indian Pharma Sector
Jedrik Hastings January 28, 2025

AbbVie and Abbott are two significant names in the pharmaceutical industry. Both companies have a shared history, but they operate independently since their separation in 2013. This article provides insights into their individual roles and collaborations, particularly in the context of the Indian pharmaceutical market. It also explores the strategic decisions that have shaped their paths and their impact on innovation and healthcare.